Patents by Inventor Lance Hultin

Lance Hultin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for determining favorable prognosis in an HIV positive subject using HLA-DR.sup.+ /CD38.sup.- CD8.sup.bright cells
    Patent number: 5470701
    Abstract: The subject invention involves an approach to determining the favorable prognosis of a subject infected with HIV. Specifically, the discovery involves the importance of the elevated presence of MHC class II antigen.sup.+ /CD38.sup.- /CD8.sup.bright cells for the prognosis of favorable outcome in HIV-infected subjects. In one example the MHC class II antigen may be HLA-DR.
    Type: Grant
    Filed: February 24, 1993
    Date of Patent: November 28, 1995
    Assignee: The Regents of the University of California
    Inventors: Janis V. Giorgi, Lance Hultin